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Abstract.  Cells interact with extracellular fibronectin 
(FN) via adhesive fibronectin receptors (FNRs) that 
are members of the very late antigens (VLAs) sub- 
group of the integrin family. In stationary fibroblasts, 
the FNR is highly organized and distributed identically 
to extracellular FN fibrils.  However, in highly migra- 
tory neural crest cells and embryonic somatic fibro- 
blasts, this organization is lost and the FNR appears 
diffuse. Similarly, oncogenic transformation typically 
leads to disorganization of the FN receptor and loss of 
matrix FN. Two models can account for these obser- 
vations. First, the FN matrix may organize the FN 
receptor at extracellular matrix contacts on the cell 
surface. Motile cells not depositing FN matrices thus 
lack organized receptors. Alternatively, as the FNR is 
required for optimal FN matrix assembly, (McDonald, 
J.  A., B. J.  Quade, T. J.  Broekelmann, R.  LaChance, 
K.  Forseman, K.  Hasegawa, and S. Akiyama. 1987. J. 
Biol.  Chem.  272:2957-2967;  Roman, J., R.  M. 
LaChance, T. J.  Broekelmann, C. J.  R. Kennedy, 
E. A. Wayner,  W. G.  Carter, J.  A. McDonald.  1989. 
J.  Cell Biol.  108:2529-2543)  and has putative 
cytoskeletal links, it could be organized from within 
the cell helping to position newly forming FN fibrils. 
To study this question, we developed peptide antibod- 
ies specifically recognizing the a5 subunit of the FNR. 
Using these antibodies, we examined the organization 
of FN and of the FNR in normal, matrix assembly in- 
hibited, and SV40-transformed human fibroblasts.  On 
FN-coated substrates, the FNR is found in focal con- 
tacts rather than diffusely on the basal cell surface, 
suggesting FNR interaction with intracellular compo- 
nents. However, when FN fibrils are deposited, the 
FNR is co-distributed with these fibrils. Preventing 
FN matrix assembly prevents organization of the 
FNR.  Moreover, when fibroblasts with well estab- 
lished FN matrices and co-distributed FNR are in- 
cubated briefly with monoclonal antibodies that block 
FNR binding to FN, the FNR is no longer co-dis- 
tributed with the FN matrix. Thus, the FN receptor is 
organized in fibrils on the cell surface in response to 
extracellular FN.  Because exogenous FN restores a 
FN matrix and receptor organization to SV40-trans- 
formed cells, the diffuse FN receptor phenotype ap- 
pears to be related to loss of the FN matrix rather 
than to impaired FNR function. These results explain 
diffusely distributed FNRs in migratory neural crest 
and embryonic fibroblasts lacking well organized FN 
matrices and emphasize the existence of separate but 
related systems controlling FN deposition and recogni- 
tion by receptor-armed cells. 
C 
ELL interaction with fibronectin (FN) l containing ma- 
trices appears  critical for embryonic development 
and cytodifferentiation,  wound healing,  and tumor 
metastasis (Bronner-Fraser,  1986; Chen et al.,  1986b; Du- 
band et al., 1986; 1988; McClay and Ettensohn,  1987; Bou- 
1. Abbreviations  used in this paper:  FN, fibronectin; FNR, FN receptor; 
IF, immunofluorescence;  KLH,  keyhole  limpet hemocyanin;  OSG,  octyl- 
thioglucopyranoside;  VN, vitronectin; VNR, VN receptor; VLA, very late 
antigen. 
caut et al.,  1984; Humphries et al.,  1986a,b).  A heterodi- 
meric transmembrane receptor of subunit composition o~5/3, 
in the (very late antigens) VLAs subfamily of integrins, also 
termed the fibronectin receptor (FNR; we use the term "FNR" 
to refer to the heterodimer of ct5/3, subunit composition  as 
defined by the cDNA sequence published by Argraves et al. 
[1987].) binds to an RGDS containing sequence in FN's car- 
boxy  terminal cell adhesive  domain and is  implicated  in 
these interactions with FN (Pytela et al., 1987; Ruoslahti and 
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1987). FN and the FNR are co-distributed in a fibrillar array 
on cultured fibroblasts (Singer et al., 1988; our observations 
in this work). Furthermore, the cell surface distribution of 
this receptor is related to cell behavior. For example, loss of 
the FN matrix and disorganization of members of the VLA 
family and probably the FNR accompanies the oncogenic 
transformation of chick fibroblasts  (Chen  et al.,  1986a). 
Similarly, migrating neural crest cells and freshly cultured 
somatic fibroblasts  lack an  organized FN  matrix and the 
VLA antigens are diffusely distributed on their surface (Du- 
band et al.,  1988). 
Fibroblast monolayers also bind FN's amino terminal do- 
main, and although this binding does not support cell adhe- 
sion it is critical for FN matrix assembly (McDonald et al., 
1982,  1987; McKeown-Longo and Mosher,  1985;  Quade 
and McDonald,  1988;  for review,  see  McDonald,  1988). 
This suggests that FN fbrils are assembled via a mechanism 
involving FN's  amino terminus and that the FNR simply 
binds to these fibrils mirroring their organization. However, 
the FNR also contributes to matrix assembly (McDonald et 
al., 1987; our observations). Thus, because the FNR may in- 
teract with the cytoskeleton (Buck and Horwitz,  1987),  it 
could be organized from within the cell and convey posi- 
tional information to newly forming FN fibrils. 
The FNR shares a common/3~ subunit with at least six 
related VLAs expressed by many cells but possesses a unique 
c~5  subunit (Hynes,  1987; Hemler et al.,  1987).  Accord- 
ingly, we raised synthetic peptide antibodies to selected poly- 
peptides from the deduced sequence of the FNR c~5 subunit 
(Argraves et al.,  1987).  An antibody to the cytoplasmic do- 
main specifically recognizes the FNR and has been used to 
study its distribution in normaI and SV40-transformed fi- 
broblasts and the mechanisms of FNR localization in fibro- 
blasts. 
Materials and Methods 
Materials 
All organic chemicals were of analytic grade and were obtained from Sigma 
Chemical Co. (St. Louis, MO) or Fisher Scientific Co. (Pittsburgh, PA) un- 
less otherwise specified. 
FNR Purification 
Human  placental  FNR  was purified as described (Pytela et al.,  1987). 
Ground  placenta was stirred in  Dulbecco's PBS  (l:l,  wt/vol) containing 
1 mM CaCI2,  1 mM MgC12, and 1 mM PMSF (buffer A) plus 50 mM oc- 
tylthioglucopyranoside (OSG) for 1-2 h at 4°C. After centrifuging (25,000 
g, 30 rain, 20°C) the supernatant was chromatographed on (a) a Sepharose- 
4B filter column; (b) an 18-ml Sepharose-4B column CNBr conjugated to 
10 mg of the synthetic peptide KYAVTGRGDS to remove vitronectin recep- 
tors (VNR); (c) a 22-ml Sepharose-4B column CNBR conjugated to IO3 mg 
of the 1  lO-kD thermolysin-released  cell binding domain of FN (Zardi et al., 
1985) to bind the FNR.  The FNR was eluted from the ll0-kD fragment 
column with buffer A lacking divalent cations and containing 10 mM EDTA 
and 25  mM OSG and chromatographed on a  5-ml wheat germ aggluti- 
nin-Sepharose column (Pharmacia Fine Chemicals, Piscataway,  NJ) in 10 
mM Tris-HCL, pH 7.4, containing 25 mM OSG,  150 mM NaCl,  1 mM 
CaCI2,  1 mM MgCI2,  1 mM PMSE and eluted with the same buffer con- 
taining 0.4 M N-acetyl glucosamine. Fractions were analyzed by 5-10 per- 
cent gradient SDS-PAGE and silver staining (Phast System; Pharmacia Fine 
Chemicals). For immunoblotting, purified FNR was electropboresed on a 
7% polyacrylamide gel, transferred to nitrocellulose and visualized as de- 
scribed (Towbin et al.,  t979;  McDonald et al.,  1987). 
Synthetic Peptides and Antisera 
Four hydrophilic peptide sequences (residues 65-73, 811-823, 886-89% and 
1039-1049)  were selected (see Doolittle,  1986)  from hydropathy analysis 
(Kyte and  Doolittle,  1982;  Doolittle,  1986)  of the deduced cDNA  se- 
quence of the FNR ot subunit (Argraves et al., 1987).  Each peptide was syn- 
thesized with a  cysteine residue at  its amino terminus for cross-linking. 
After purification by C-18 reverse-phase HPLC using a 0 to 60% gradient 
of acetonitrile in 0.1%  trifluoroacetic acid, disulfide cross-linked peptide 
dimers were reduced with 50 mM DTT followed by Sephadex G-10 chroma- 
tography. Peptide concentration was estimated with dithio-bis-nitrobenzoate 
(Janatava  et  al.,  1968)  and  each  peptide conjugated to  keyhole  limpet 
hemocyanin (KLH)  using  N-succinimidyl-bromoacetate (NSB)  at  a  1:1 
(wt/wt) ratio of peptide/KLH (Bernatowicz and Matsueda, 1986).  Peptide- 
KLH conjugates were emulsified with complete Freund's adjuvant and four 
rabbits were immunized subcutaneously with 400 p.g each of peptide-KLH 
conjugate and reimmunized every 2 wk with 200/zg of peptide-KLH con- 
jugate emulsified in incomplete Freund's adjuvant. After 2-4 weeks animals 
were bled, the serum titered by ELISA on purified FNR, the IgG purified 
(McKinney and Parkinson,  1987),  and antipeptide 1gG affinity  purified by 
chromatography  on  a  peptide-hexane-diamine-Sepharose-CLB4 column 
cross-linked with N-succinimidyl-bromoacetate. 
FN Fragments and Antibodies 
A mouse mAb to the ~ subunit of the VNR was generously provided by Dr. 
D. Cheresh of the Scripps Clinic Foundation (Cheresh and Harper,  1987). 
In IMR-90 cells, mABs to the c¢ and/~ subunit of the VNR gave identical 
staining results with localization to focal contacts. The anticollagen receptor 
monoclonal antibody PIH5 to the c~2 subunit (Wayner and Carter,  1987; 
Takada  et al.,  1988) and the anti-FNR c~5 monoclonal antibody P1F8 have 
been described (Wayner et al.,  1988). 
FN and FN fragments were isolated by described methods (McDonald 
et al.,  1987; Zardi et al.,  1985) and were judged greater than 95% pure by 
SDS-PAGE and protein staining (Phast System; Pharmacia Fine Chemi- 
cals). VNR was purified from serum as described (Hayashi et al.,  1987). 
Cell Culture 
The fetal human lung fibroblasts lines IMR-90, WI-38 and the SV40 trans- 
formed line WI-38 VA-13 were obtained from the ATCC and were cultured 
in DME (Washington University Tissue Culture Support Center) (IMR-90) 
or RPMI  1640  (Wl-38 and WI-38 VA-13) supplemented with  10%  heat- 
inactivated FBS (Hyclone Laboratories, Logan, UT), 2 mM L-glutamine 
and  antibiotic-antimycotic solution (Gibco  Laboratories,  Grand  Island, 
NY) in a 5% CO2/95% air atmosphere. Antibodies or FN fragments were 
dialyzed against DME (three changes, 24 h) before use in cell culture. Hy- 
bridoma-conditioned medium containing the antireceptor antibodies PtF8 
and P1H5 was dialyzed similarly, and fresh, heat-inactivated FBS added to 
20%  final concentration. 
lmmunofluorescence 
Cells were trypsinized and plated either in 8 chamber LabTek microslides 
or on number 1 thickness coverslips and cultured overnight or as specified. 
For double label immunofluorescence (IF), staining cells were fixed with 
freshly prepared 1% paraformaldehyde, rinsed with 10 mM Tris-HCL con- 
taining 150 mM NaCL, pH 7.4, and 1 mg/ml of heat-denatured serum albu- 
min (TBS-BSA), permeabilized with 0.1% Triton X-100  in TBS,  and in- 
cubated with a mixture of 1 ~tg/ml of affinity purified Ab 33 antireceptor 
antibody and 10 p.g/ml of a mAb (52DH1) to the EIIIA exon of FN (Vartio 
et al.,  1987)  in TBS-BSA for 30 rain at room temperature. After rinsing 
with TBS containing 0.5% Triton X-103 and 1% normal goat serum, speci- 
mens were incubated with fluorescent-labeled secondary antibodies shown 
in control studies not to cross react with the irrelevant primary antibody 
used in the same experiment, mounted in Gelvatol (Rodriguez and Dein- 
hardt, 1960) containing p-phenylenediamine and examined with a Biopbot 
(Nikon Inc., Garden City, NY) equipped with epifluorescence optics. For 
interference reflection microscopy, cross polarizers were mounted and cells 
cultured on coverslips were illuminated using monochromatic green light 
supplied by the HBO 200 Hg lamp and a 543 nm filter.  Film (Tmax 400; 
Eastman Kodak Co., Rochester, NY) was exposed at 800 ASA and devel- 
oped at its rated speed (Tmax developer; Eastman Kodak Co.). 
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Cell surface iodination was performed with lactoperoxidase  and glucose ox- 
idase (Leiben et al., 1982).  The FNR was immunoprecipitated from Triton 
X-100 lysates of  IMR-90 cells with 100 t~g/ml of  Ab 33 using IgSORB (heat- 
killed,  formalin-fixed Cowan strain Staphylococcus  aureus;  the Enzyme 
Center,  Boston,  MA)  rather than  protein  A-Sepharose (Roberts et al., 
1988). In preclearing immunoprecipitation experiments, 100 #1 ofa 2 % Tri- 
ton X-100 lysate, representing 20%  of the contents of a surface-iodinated 
lO-cm culture dish of IMR-90 or Wl-38 cells, was incubated at 4°C for 1 h 
With an equal volume of hybridoma supernatant containing PIH5 or P1F8 
mAb or with 10 ~tg of Ab 33. Then, 7.5 #g of rabbit anti-mouse IgG was 
added (this step was omitted for Ab 33). After 30 rain, the mixture was in- 
cubated with 20 #1 of IgSORB for 45 min, centrifuged at 10,000 g  for 10 
min, and the supernatant reimmunoprecipitated by the addition of hybrid- 
oma-conditioned supernatant. This procedure was repeated a total of three 
times. 
Other Reagents and Methods 
MAb to vinculin was from Miles Scientific (Naperville, IL), Texas red-con- 
jugated phalloidin was from Molecular Probes Inc. (Junction City, OR), and 
rabbit polyclonal antitalin antibody (Burridge and Feramisco, 1980) was a 
generous gift of Dr. K. Burridge, Department of Cell Biology,  University 
of North Carolina. Glass coverslips were coated with proteins by incubation 
with the specified concentration of ligand overnight, followed by several 
rinses in sterile PBS or by covalent coupling of 25 #g/ml ligand (Aplin and 
Hughes,  1981). 
Results 
Synthetic Peptide Antibody Characterization 
Synthetic peptide antibodies to an amino terminal sequence 
of the 0/5 subunit (residues 65-73) immunoblot but do not 
recognize native FNR.  The peptide corresponding to resi- 
dues 886-897 was not immunogenic whereas the peptide se- 
quence from 811-823 yields antibodies recognizing the puri- 
fied FNR by ELISA and by immunoblotting (data not shown). 
Only the cytoplasmic domain peptide corresponding to resi- 
dues 1039-1049 elicited rabbit antibodies (Ab 33) recogniz- 
ing native FNR. By immunoblot analysis, Ab 33 recognizes 
unreduced purified FNR ~t subunit and, after reduction, the 
25-kD light chain carboxyl terminal polypeptide (Argraves 
et al.,  1987) (Fig.  1). Ab 33 immunoprecipitates a single 0/ 
subunit and a/3 subunit from extracts of IMR-90 cells meta- 
bolically labeled overnight, but not the pre-/~ precursor of  the 
mature ~ subunit, consistent with a  subunit interaction only 
with the mature/3 subunit (Fig.  2 A, lane C).  In contrast, 
the polyclonal antibody Ab  14.3  to the human  FNR that 
recognizes the common/~ subunit as well as the 0/5 subunit 
(Roberts et al.,  1988)  immunoprecipitates polypeptides of 
165  kD  representing the 0/~  subunit  of the VLA  complex 
(data not shown),  150 kD representing at least the 0/2, 0/3, 
0/5 and 0/6 subunits, the 120 kD mature ~t  subunit, and the 
ll0-kD pre-~ subunit (Fig.  2 A, lane B and data not shown). 
The relationship of the antigen recognized by antibody Ab 
33 to other members of the integrin family of receptors was 
investigated by sequential immunoprecipitation with mAbs 
P1H5 or P1F8 that inhibit cell adhesion to collagen and FN 
and that recognize VLAs 2 and 5, respectively (Wayner and 
Carter, 1987,  1988; Takada et al., 1988) or with Ab 33 (Fig. 
2 B). mAb P1F8 to the 0/5 subunit removed all antigen rec- 
ognized by Ab 33 and vice versa whereas mAb PIH5 did not 
remove the Ab 33 antigen (Fig. 2). Thus, P1F8 and Ab 33 
recognize the 0/5/3~ complex. In addition, the 0/2 and 0/s sub- 
units synthesized by IMR-90 are recognized by mAb PIH5 
Figure 1. Immunoblot analysis of Ab 33. Purified human placental 
FNR was transferred to nitrocellulose and detected by protein stain 
(left) or with Ab 33 (right). The positions of the ct subunit (Heavy 
+ Light Chain) in the unreduced sample and of the light chain in 
the reduced sample are indicated. Ab 33 recognizes the heavy plus 
light chain in the unreduced sample and only the light chain in the 
reduced sample. 
and P1F8 respectively, although as discussed below these an- 
tibodies do not stain IMR-90 cells.  Similar preclearing ex- 
periments performed with Triton X-100  lysates of surface- 
labeled HT-1080 cells demonstrate that preclearing with an 
0/3 subunit specific mAb also had no effect on precipitation 
of the Ab 33 antigen (data not shown). We conclude that, in 
IMR-90 and HT 1080 cells, Ab 33 recognizes the 0/5 sub- 
unit of the VLA family of integrins but not the o/j, 0/2, 0/3, 
or ol  4 subunits. 
Localization  of the FNR in Cultured Fibroblasts 
By IF,  the FNR is distributed in permeabilized IMR-90 fi- 
broblasts in a striking fibrillar pattern mirroring that of FN 
(Fig. 3, A and B). Nonpermeabilized cells do not stain (Fig. 
3,  C  and D),  confirming as does microinjection (data not 
shown) the intracytoplasmic localization of the epitope. At 
concentrations above 1 #g/ml, increased diffuse cell surface 
staining and some nonspecific nuclear staining is seen. Ex- 
cess peptide antigen blocks all except the nonspecific nuclear 
staining by Ab 33 (Fig. 3, Eand F). To establish the relation- 
ship of the FNR complex to other adhesive or cytoskeletal 
macromolecules, we localized actin, the VNR, vinculin, and 
talin by double label IF (as only a rabbit antiserum was avail- 
able to talin,  its distribution was compared only with that 
of FN). Shortly after fibroblasts are plated on serum or vi- 
Roman et al.  Fibronectin Receptor Organization  253 i Figure 2. Immunoprecipitation of [35S]methionine-labeled  IMR-90 human lung fibroblasts with antibodies to the FNR or other VLAs. (A) 
IMR-90 was labeled overnight and Triton-X100  extracts immunoprecipitated (Materials and Methods). Lane A, preimmune IgG. Lane B, 
Ab 14.3 polyclonal antiplacental FNR (Roberts et al.,  1988).  Lane C, Ab 33. The polyclonal anti-FNR immunoprecipitates four polypep- 
tides of •170  kD (unlabeled) (that is, the VLA a~ subunit [data not shown],  140 kD u  [labeled  1] that includes the a  2, 3, 5, and 6 sub- 
units [Fig.  2 B and data not shown],  120 kD B [labeled 21, and  110 kD pre-/$ [labeled 3]) whereas Ab 33  immunoprecipitates only the 
a5 and mature/$ subunit. Addition of excess peptide antigen blocks a  and ~ subunit immunoprecipitation by Ab 33 (not shown).  (B) Im- 
munoprecipitation of Triton extracts of ~25I surface-labeled IMR-90 fibroblasts with mAbs to the ~2 (P1H5) or a5 (PIF8) subunits or with 
Ab 33. A Triton lysate was immunoprecipitated twice with Ab 33 (left), mAb PIF8  to the c~5~t complex (center), or P1H5 to the c~2/3~ com- 
plex (right) (Wayner and Carter,  1987; Wayner et al.,  1988).  Ab 33  removes the t~ and ~  subunits cross-reacting with the u5  subunit 
specific antibody P1F8, but not the a  and associated/3 subunits cross-reacting with the uz specific antibody P1H5. Similarly, P1F8 removes 
all ct and associated/3 subunits cross-reacting with Ab 33, but has no effect on immunoprecipitation with P1H5. Thus,  P1F8 and Ab 33 
recognize the same cts/~t complex or FNR.  In addition,  IMR-90 expresses significant  quantities of the c~2/~j complex, as well as of the 
c~3/~t complex (data not shown). 
tronectin-coated  VN  glass,  the  FNR  is  localized  in  short 
stitches on the cell surface associated with FN (Fig. 4, A and 
B). After cell spreading is complete and an extensive FN ma- 
trix is formed, the FNR ot subunit remains colocalized with 
extracellular FN. Actin fibers (Fig. 4, Cand D) co-align with 
but only rarely appear to terminate at FNR fibrils present in 
extracellular matrix contacts. In contrast, the VNR localizes 
primarily at the cell periphery in focal contacts (Fig. 4, E and 
F) but not in extracellular matrix or close contacts. Vinculin 
(Fig.  4,  G  and H) and talin (data not shown) are present at 
both focal and extracellular contact sites.  Thus,  in IMR-90 
cultured  overnight  in  serum containing  medium the  VNR, 
vinculin,  and talin but not the FNR are in focal contacts,  in 
agreement with  FN-independent  attachment  and  spreading 
of  IMR-90  on  serum-coated  surfaces  (McDonald  et  al., 
1987). 
FNR and VNR Respond to Ligand-Coated Substrates 
by Localizing in Focal Contacts 
On VN-coated substrates, the VNR is found in focal contacts, 
whereas  the  FNR remains  in  extracellular  matrix  contacts 
(Fig. 5, A and B). In contrast, on FN-coated glass, the FNR 
was  organized  in  focal  contacts  1  h  after  plating  (Fig.  5, 
D-F). A striking, circular, wavelike pattern of FNR distribu- 
tion was seen in some cells on FN  (Fig.  5  F).  By analogy 
to focal contact formation during fibroblast locomotion, this 
is presumably because of cyclic extension of nearly circum- 
ferential  lamellipodia  followed  by  focal  contact  formation 
(Abercrombie, 1980). In 10% FCS on FN-coated glass, both 
the FNR and VNR were found in focal contacts (Fig.  5  C), 
whereas  in  serum-free  medium only the FNR was present 
(not shown). 
Effect of  Reagents Blocking the Amino Terminal 
Matrix Assembly Domain of  FN, the CeU Adhesive 
Domain, or Both on Expression  and Organization  of 
FN and the FNR 
When IMR-90 fibroblasts are cultured in 10%  serum for 48 
h,  typically about 60-80  percent of newly synthesized  FN 
is deposited on the cell surface and most is disulfide cross- 
linked into multimers. To quantify FN matrix assembly (see 
McDonald et al.,  1987,  1988; Quade and McDonald,  1988) 
and cell surface FNR expression, IMR-90 were cultured for 
48 h with FN fragments or anti-FN antibodies,  the cell sur- 
face polypeptides iodinated,  and the cell layer lysed either 
in  SDS  containing  DTT (for FN  immunoprecipitation,  see 
The Journal of Cell Biology, Volume 108, 1989  2532 Figure 3. Distribution of the FNR and cellular FN in IMR-90 fibmblasts. FNR (A) and FN (B) in fixed and permeabilized cells. FNR 
in Triton permeabilized (C) and nonpermeabilized  (D) fibroblasts. FNR staining in the absence (E) and presence (F) of 1 t~g/ml  of  peptide 
antigen. Only residual nuclear staining remains. Bar, 20 #m. 
McDonald et al., 1987) or Triton X-100 (for FNR immuno- 
precipitation). The lysates were counted, and samples con- 
raining the same cpm were immunoprecipitated and labeled 
polypeptides displayed by SDS-PAGE and autoradiography. 
Thus, the results reflect relative surface abundance of FN 
and FNR. However, total surface labeling of IMR-90 cul- 
tured with the antibodies or fragments varied <16 percent 
(data not shown).  The  autoradiograms and the results of 
quantitative laser scanning densitometry are shown in Fig. 
6 and IF staining in Fig. 7. 
The 70-kD amino terminal matrix assembly domain of FN 
inhibits cell surface FN accumulation by 90%  (Fig. 6) and 
results in short streaks of FN and FNR on the cell surface 
but completely absence of intercellular FN fibrils (Fig. 7, A 
and B). In contrast, mAb N-294 to FN's cell adhesive do- 
main inhibits FN deposition by •40%  (Fig. 6), and the cells 
exhibit normal appearing, albeit reduced, numbers of inter- 
cellular FN fibrils (see Fig. 8). Combining the 70 kD frag- 
ment with mAb N-294 or with a 120 kD cell adhesive frag- 
ment of FN strikingly inhibits FN deposition (Fig. 6) and 
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tracellular fibrils. The altered organization of the FNR by IF 
staining is clearly not because of decreased FNR expression, 
but reflects altered distribution of the FNR on the cell surface 
(compare Fig. 6,  Control and MAb N-294  +  70 kD lanes). 
The inhibition of FN deposition is specific to these frag- 
ments or antibodies, as neither fragments encompassing the 
entire remaining sequence of  FN apart from the amino termi- 
nus and high affinity cell adhesive fragment (viz, the 60-kD 
collagen binding domain or the catheptic carboxyl terminal 
dimer of 140 kD (Quade and McDonald,  1988) nor other 
mAbs to FN inhibit FN deposition (McDonald et al.,  1987). 
Antibodies Inhibiting FN-FNR Binding Disorganize 
the FNR 
The need to block both the amino terminal and cell adhesive 
domains of FN to prevent FNR organization suggests that the 
FNR must bind to extracellular FN to organize in fibrils on 
the cell surface. To test this, we utilized two mAbs that in- 
hibit FN-mediated cell adhesion by blocking FN-FNR inter- 
action, N-294 to FN (McDonald et al.,  1987), and P1F8 to 
the or5 subunit of the FNR (Wayner et al.,  1988). As a con- 
trol, we used P1H5, an mAb to the VLA c~2 subunit (Takada 
et al.,  1988) that inhibits cell adhesion to collagen but not 
to FN (Wayner and Carter,  1987). 
Two types of experiments were performed. First, IMR-90 
were cultured overnight and allowed to establish an extensive 
pericellular FN matrix with colocalized FNR (Fig. 8, A and 
B). Then, the medium was changed to one conditioned with 
the P1F8 hybridoma line or containing N-294 at 100/~g/ml, 
and at intervals fixed, permeabilized, and stained for detec- 
tion of FN and FNR. By 15 min, there was a clearly visible 
reduction in FNR co-distribution with FN that, by 30 min, 
appeared virtually complete in P1F8 anti-FNR medium (Fig. 
8,  C and D). Thus, inhibiting FN-FNR interactions results 
in a redistribution of the FNR away  from FN fibrils. 
Second, IMR-90 were cultured either with purified IgG 
(N-294) or with hybridoma-conditioned medium (P1H5  or 
P1F8) overnight, and were fixed and stained using one of the 
following protocols: (a) rhodamine isothiocyanate goat anti- 
mouse IgG to visualize the monoclonal antireceptor antibod- 
ies; (b) Ab 33 anti-FNR followed by FITC-goat anti-rabbit 
IgG to detect the FNR; (c) the anti-FN EDIIIA mAb followed 
by a  mixture of FITC-goat anti-rabbit IgG and rhodamine 
isothiocyanate goat anti-mouse IgG to detect both FNR and 
FN. Even though their respective antigens were abundant and 
readily  immunoprecipitated  from  surface-labeled  IMR-90 
(see Fig. 2 B), neither P1F8 nor P1H5 antireceptor antibodies 
alone stained IMR-90 cells. This may reflect the fact that these 
antibodies do not recognize ligand-occupied receptors (Way- 
ner et al.,  1988).  In any event, another mouse mAb could be 
used to detect EDIIIA containing FN. 
Culturing IMR-90 with N-294 (not shown) or P1F8 (Fig. 
8, E and F) reduces, but does not eliminate, FN fibril forma- 
tion and largely prevents FNR co-distribution with the FN 
matrix. The control anti-or2 antibody P1H5 had no effect on 
FN or FNR by IF (data not shown).  Thus, inhibiting FN- 
receptor binding with antibodies directly either against the 
receptor binding site on FN (N-294) or to the ligand binding 
site of the FNR (P1F8) has two effects. If FN-FNR interac- 
tion is blocked after the FN matrix is assembled, co-localiza- 
tion of the FNR with FN is completely reversed within 30 
min without detectable effects on the pericellular matrix. If 
FN-FNR interaction is inhibited beginning when the fibro- 
blasts are plated, FN matrix assembly is impaired and the 
FNR is much less organized. 
Effect of Cytochalasin B on FN and FNR Organization 
The above results demonstrate that the FN matrix exhibits a 
strong  influence on FNR distribution.  Although the actin 
microfilament system is required for FN matrix formation 
(Lyubimov and Vasiliev,  1982), it is not clear if this system 
is required to maintain the association of FN and FNR after 
an FN matrix is established. Addition of cytochalasin B re- 
sults in an accelerated loss of FN from the cell surface and 
cell retraction termed "arborization" However, substrate as- 
sociated and pericellular FN matrix is largely retained for 
over 2 h (Ali and Hynes, 1977; Mautner and Hynes, 1977). 
Cytochalasin B treated IMR-90 completely lose organized 
actin. However, FN and FNR organization was not detect- 
ably altered in confluent IMR-90 with abundant matrix FN 
exposed to cytochalasin B for 30 min or 4 h (Fig. 9). When 
subconfluent cells were exposed to cytochalasin B, cells re- 
taining organized FN fibrils also retained organized receptor 
networks whereas cells without detectable fibrillar FN had 
more diffusely distributed receptors (data not shown).  Al- 
though real time imaging of individual cells is required to de- 
termine if the cells lacking an organized matrix and receptor 
complex did so before cytochalasin B treatment, it is clear 
that many cells retain more or less normal matrix and recep- 
tor organization for a considerable period despite the com- 
plete loss of organized actin. 
SV40 Transformation Inhibits FN Matrix Accumulation 
and FNR Organization but Exogenous FN Restores a 
Matrix and FNR Organization 
The FN matrix of WI-38 fibroblasts is identical to that of 
IMR-90 by IF staining, and the FNR was co-distributed with 
this matrix (data not shown). By contrast, the SV40-trans- 
formed line WI-38 VA13 has  scant detectable surface FN 
fibrils and mostly diffuse FNR (Fig. 10, A and B). Culturing 
WI-38 VA13 with 50/zg/ml of plasma FN restores a FN ma- 
trix to the cell surface and results in complete FNR reorgani- 
zation, although their more epithelial morphology is not al- 
tered (Fig.  10,  C and D). 
Figure 4. Localization of FNR with other adhesion receptors and cytoskeletal components. FNR (A) and FN (B) in an IMR-90 cell 2 h 
after attachment to a serum-coated glass substrate. The FNR and FN fibrils are co-distributed. FNR (C) and actin (D) in IMR-90 fibroblasts. 
The receptor complex is co-aligned with actin cables, and, in some cases, actin cables appear to terminate at FNR fibrils. FNR (E) and 
VNR (F) on IMR-90 cells after overnight culture on serum-coated glass substrate. The FNR is concentrated in fibrils in the central portion 
of the cells, whereas the VNR is primarily localized in focal contacts at the cell periphery. FNR (G) and vinculin (H) in IMR-90 cultured 
in serum overnight. Vinculin is found both at focal contacts and in extracellular matrix contacts containing the FNR whereas the FNR 
is absent from the focal contacts. Talin is distributed similarly to vinculin (data not shown). Bars, 20 #m for each pair of photomicrographs. 
Roman et al. Fibronectin Receptor Organization  2535 Figure 5. Localization of FNR and VNR in IMR-90 spread upon FN- or VN-coated substrates. (A and B) VNR and interference reflection 
image of the edge of an IMR-90 spread on a VN-coated surface for 1 h in serum containing medium. Note that the VNR (A) is localized 
almost exclusively at focal contacts (/arge arrows) as shown by the corresponding interference reflection image in B. The FNR was not 
detectable in focal contacts, but remains diffusely distributed (not shown). (C-E) VNR (C), interference reflection image (D), and FNR 
(E) in an IMR-90 plated on a FN-coated glass coverslip in the presence of 10% FCS. The VN and FNRs are found in focal contacts (large 
arrows), whereas the FNR is also found in extensive extracellular matrix contact sites as shown by the light grey and white lines in the 
interference image (small arrows in D and E). F displays a striking circular pattern of the FNR in focal and extracellular matrix contacts 
seen in some IMR-90 spreading on a FN substrate. Bar, 20 #m. 
Discussion 
Synthetic Peptide Antibody Characteristics 
Synthetic peptide antibodies to a  sequence comprising the 
last I 1 residues of the cytoplasmic domain of the human FNR 
~5  subunit recognize an epitope present on the light chain 
of ligand purified FNR preparations and cross react with na- 
tive human,  mouse (Holers et al.,  1989) and goldfish (data 
not shown) FNR. Peptide antibodies to a sequence from the 
cytoplasmic domain of the B~ subunit also recognize diverse 
species (Marcantonio and Hynes,  1988) demonstrating that 
The Journal of Cell Biology, Volume 108,  1989  2536 Figure 6. Cell surface FN and FNR expression in matrix inhibited 
IMR-90. A depicts autoradiography of surface iodinated IMR-90 
immunoprecipitated with anti-FN (/eft) and FNR (right) antibodies 
in matrix competent and inhibited IMR-90 ceils. For FN (left), the 
lanes are PI, preimmune control (preimmune controls were run for 
each condition and were identical, a representative lane is shown 
here);  Control, no additions; 70 kD, 0.75 mg/ml of 70-kD amino 
terminal FN fragment; 120kD, 1.37  mg/ml of  the 120 kD cell adhe- 
sive FN fragment; 70 4- 120kD, a mixture of  the 70 kD (0.8 mg/ml) 
and 120 kD (1.37 mg/ml) FN fragments; MAb N-294, monoclonal 
N-294 to FN's cell binding site, 100/~g/ml; N-294 4- 70kD, a mix- 
ture of monoclonal N7294 (100/~g/ml) and 70 kD (0.8 mg/ml) FN 
fragment.  For FNR (right), duplicate  immunoprecipitates from 
separate cultures are  shown. Concentrations of inhibitors are as 
above. B displays the relative quantities of surface FN and FNR de- 
termined by laser scanning densitometry. Cell surface FNR expres- 
sion is not decreased by any of  the fragments or antibodies, and may 
even be increased in some cases. 
both cytoplasmic domains of the FNR are highly immuno- 
genic, and yet conserved and presumably critical for func- 
tion. 
Preclearing experiments with mAbs demonstrate that Ab 
33 appears to recognize only the a5 subunit, agreeing with 
the fact that no significant identity has been detected within 
the cytoplasmic domains  of the VLA ct  subunits thus  far 
(M.  E. Hemler, personal communication). Immunoprecipi- 
tation with the specific polyclonal antibody 14.3 to the FNR 
clearly demonstrates the need for ct subunit specific immu- 
noreagents. Antibody 14.3 immunoprecipitates VLAs 1, 2, 
3,  and 5  because of c~-/3 subunitinteractions.  In  fact, the 
a5/3, complex or FNR is not even a major component of the 
VLAs expressed by IMR-90 fibroblasts (in Fig. 2, compare 
lane B representing all VLAs and lane C,  containing total 
FNR). 
Implications for lntegrin Structure 
Antibodies to the o~5 subunit (our observations in this work) 
and to the/if,  subunit putative cytoplasmic domains (Mar- 
cantonio and Hynes,  1988) only stain permeabilized cells. 
As these domains follow a single putative transmembrane se- 
quence (Argraves et al.,  1987),  each subunit of the FNR 
must consist of a large amino terminal extracellular domain, 
a single transmembrane sequence, and a short carboxyl ter- 
minal cytoplasmic domain as previously proposed (Argraves 
et al.,  1987;  Hynes,  1987). 
Localization of the FNR and VNR in Cultured 
Fibroblasts 
An organized FN matrix is required for fibrillar organization 
of the FNR at extracellular matrix contact sites. FN binding 
is required for FNR organization at these sites as antibodies 
inhibiting binding displace the FNR. On serum-coated sur- 
faces,  the  FNR  is  found in  extracellular matrix  sites  as- 
sociated with FN, vinculin, and talin as previously described 
(Singer et al.,  1988). However, on FN- or VN-coated sub- 
strates in the absence of serum, the cognate receptor local- 
izes in adhesive focal contacts, whereas the other remains 
diffusely distributed and is not detectable at focal contacts 
(our observations in this work; Singer et al.,  1988; Dejana 
et al.,  1988).  As  the  substrate  is  more or less  uniformly 
coated with ligand under these circumstances the adhesive 
receptor might be expected to be diffusely distributed on the 
basal cell surface. However, both VNR and FNR accumulate 
at focal contacts,  suggesting additional interactions within 
the cell.  In endothelial cells,  clustering of the /3~  subunit 
and of the VNR receptor precedes focal contact formation 
(Dejana et al.,  1988). Using the fluorescence recovery after 
photobleaching technique, it has further been demonstrated 
that the mobility of VLA complexes is decreased by associa- 
tion at focal or matrix contacts. Receptors associated with 
ECM  streaks or focal contacts are largely immobile (18% 
mobile  fraction) whereas  diffuse receptors in  the  plasma 
membrane are much more mobile (66%  mobile fraction) 
(Duband et al.,  1988). This is also true for the FNR. When 
mAb P1F8 was added to IMR-90 cells with established FN 
matrices and highly organized FNR, there was a complete 
loss of organized FNR structures by 30 min. 
Disorganization of the FNR in SV40 Transformed 
Fibroblasts Is not because of Defu:ient Ligand Binding 
The  FNR  is  largely,  but  not  completely, disorganized  in 
the SV40 transformed WI38 VA13 line. However, restoring 
the FN matrix with exogenous FN also restores FNR organi- 
zation. This effect could be related to associated transform- 
ing growth  factor ~  rather than the FN per  se  (Fava and 
McClure,  1987), but it seems unlikely that the diminished 
FNR organization is related to deficient ligand binding. Al- 
though  it has  been suggested that  phosphorylation of the 
FNR ~t  subunit (Hirst et al.,  1986) in cells transformed by 
viruses encoding tyrosine kinases is responsible for the ab- 
normal  distribution  of the  FNR,  impaired  FNR  function 
need not be invoked as the absence of an organized FN ma- 
trix  is  sufficient to account for diffusely organized FNR. 
Thus,  it is  not suprising  that migratory neural crest cells 
lacking a  FN matrix also have diffusely distributed FNRs 
without significantly increased VLA phosphorylation (Du- 
Roman et al. Fibronectin  Receptor Organization  2537 Figure 7. Effect of  FN fragments and mAb on FNR distribution  and FN matrix assembly. FNR (A) and FN (B) in IMR-90 cultured overnight 
with 0.75 mg/ml of the 70 kD amino-terminal fragment of FN. The controls for this experiment are shown in Fig. 3, A and B. FN fibrils 
spanning  between  cells  are absent  but shorter stitches  remain on the cell surface (B) and the FNR is organized  similarly  (A). There are 
few uninterrupted  linear receptor arrays, but many interrupted  streaks are retained.  The bright staining in B is intracellular  FN as nonper- 
meabilized  cells showed only scant stitches on their surface.  In addition, cells cultUred with the 70-kD fragment variably exhibit apparent 
increases  in staining of intracellular  FN as seen here.  FNR (C) and FN (D) in IMR-90 cultured overnight  with a mixture of 0.75 mg/ml 
of 70-kD fragment and 100 ttg/ml of mAb N-294 directed to FN's receptor binding site. Note the absent FN matrix and the corresponding 
lack of FNR organization.  Bars,  20 txm for each pair. 
band  et  al.,  1988).  Similarly,  other  cells  lacking  a  FN- 
containing  pericellular  matrix  should  lack  organized  FN 
receptors and this is true for CHO-K1 and L-cells (our un- 
published results). 
The diminished FN matrix in most transformed cells may 
be because of deficient FN synthesis,  cell surface binding, 
assembly, or FN proteolysis (Wagner et al.,  1981;  Yamada, 
1978; Fegan et al., 1981; Chen and Chen, 1987) but probably 
not to defective FN (Wagner et al.,  1981).  In SV40 trans- 
formed WI-38 fibroblasts,  deficient amino terminal binding 
appears to be important (McDonald et al., unpublished data). 
FNR Cytoskeletal Interactions 
Avian integrins  of uncertain  subunit composition that bind 
The Jourtlal of Cell Biology, Volume  108, 1989  2538 Figure 8. Inhibiting FN-FNR binding with mAbs to FN reverses FNR organization.  (.4 and B) IMR-90 cultured overnight and the FNR 
(A) and FN (B) detected by IE C and D show a parallel  well that was rinsed and incubated with hybridoma-conditioned medium containing 
the anti-FNR P1F8 for 30 min. Although the FN matrix remains  intact  (D), there is almost no associated  FNR (C). E and F  show the 
results  of culturing IMR-90 overnight with the anti-FNR P1F8. There is a significant  decrease in FN matrix deposition, and FNR co- 
distribution.  Bar,  20/~m. 
FN also bind  weakly to talin,  and the talin-receptor  com- 
plexes bind vinculin  (Horwitz  et al.,  1986).  However,  the 
molecules involved in mammalian FNR-cytoskeletal interac- 
tions remain unknown.  Both talin and vinculin are present 
at the extracellular matrix contacts containing FNR and FN, 
but it is not known if they interact directly with the FNR. 
It does seem, however, that actin microfilaments do not play 
a  significant short term  role in maintaining  (as opposed to 
initiating) FNR organization as collapsing the actin cytoskel- 
eton had no obvious effects on FN or FNR distribution.  Syn- 
Roman et al. Fibronectin Receptor Organization  2539 Figure 9. Effect of cytochalasin B on FNR and FN distribution in IMR-90. (A) Actin staining in IMR-90 exposed to 10/~g]ml  of  cytochalasin 
B for 30 min or not (B). FNR (C) and and FN (D) in control cells. (E and F) Cytochalasin B-treated (30 min, 10 #g/ml) cells. The FNR 
(E) and FN matrix (F) remain orgnized despite extensive cell arborization (not shown). Similar results were obtained with confluent 
monolayers exposed to cytochalasin B for 4 h (not shown). 
thetic peptide antibodies to cytoplasmic domains should be 
useful tools to dissect FNR interactions with putative cyto- 
skeletal links. 
A  Model  for FN Matrix Assembly Incorporating 
Bidirectional Information Transfer between the FN 
Matrix and the FNR 
Previous studies demonstrated that FN fragments binding to 
the FNR did not inhibit binding of exogenous radiolabeled 
FN to fibroblast monolayers (McKeown-Longo and Mosher, 
1985)  even though FN binding to suspended fibroblasts is 
mediated via the FNR binding site (Akiyama and Yamada, 
1985).  This paradox may be explained by the observation 
that suspended fibroblasts do not bind to FN's amino termi- 
nal matrix assembly domain (Quade and McDonald,  1988), 
possibly  because  an  intact  actin  microfilament system  is 
required (Barry and  Mosher,  1988).  Although  we cannot 
conclude that the FNR is absolutely required for FN matrix 
The Journal  of Cell Biology, Volume  108, 1989  2540 Figure 10. FN and FNR in SV40-transformed human fibroblasts. (,4 and B) FNR and FN in WI38 VA13 SV40-transformed human lung 
fibroblasts. The FNR is largely disorganized, and there is a scant FN matrix. (C and D) FNR and FN in WI38 VA13 fibroblasts cultured 
with 50/~g/ml of human plasma FN overnight. Note that the FNR is co-distributed with the now abundant FN matrix. Bars, 20 #m for 
each pair. 
assembly, cell surface FN accumulation is reproducibly in- 
hibited by high concentrations of cell adhesive fragments (ei- 
ther the 120 kD catheptic fragment (our observations in this 
work) or the similar chymotryptic peptide (data not shown)) 
or mAb N-294 (Fig.  6).  This effect is specific (McDonald 
et al.,  1987;  Quade and McDonald,  1988).  Moreover, re- 
agents inhibiting both amino terminal and RGD binding sites 
produce additive effects on FN accumulation, and both are 
required to prevent all traces of FN (and FNR) organization 
on the cell surface. However, until we are confident that com- 
plete inhibition of FNR function is achieved, quantitative es- 
timates of its importance in FN matrix assembly are not pos- 
sible (McDonald,  1988). 
Inhibiting amino terminal binding by the 70 kD fragment 
in IMR-90 leaves ~10% of surface FN as short streaks on 
the cell surface associated with the FNR (Fig. 7, A and B). 
Assuming  this  reflects the phenotype associated  with  FN 
binding  mediated  via  an  RGD  and  adjacent  affinity  site 
(Obara et al., 1988) dependent mechanism, then FN organi- 
zation occurs without the involvement of FN's amino termi- 
nal domain. Clearly the FNR is not critical for fibril elonga- 
tion, as amino terminal inhibitors alone are very efficient at 
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al.,  1987;  our observations in this work) whereas FNR in- 
hibitors  do not seem to be.  Although  by no means proof, 
our results are compatible with a model in which fibril "nu- 
cleation"  occurs  via  the  FNR  followed by  elongation and 
cross-linking requiring  participation  of the amino terminal 
matrix assembly domain (McDonald et al., 1987; McDonald 
1988). Alternatively,  it is possible that the occupied FNR in- 
teracts with a distinct "matrix assembly receptor" proposed 
by  McKeown-Longo  and  Mosher  (1985),  enhancing  cell 
binding  to  FN's  amino  terminal  matrix  assembly  domain 
(McDonald,  1988).  Regardless  of  formal  mechanism(s), 
there is clearly a mutual interdependence of the FN adhesive 
receptor complex, amino terminal  binding activity and FN 
matrix assembly (McDonald,  1988). 
There Are Dual Systems of FN Deposition in the 
Extracellular Matrix and Recognition 
Organization  of the FNR by the extracellular matrix is sensi- 
ble viewed in the context of dual systems of FN matrix de- 
position and recognition (McDonald,  1988).  The profound 
change in FNR organization associated with FN matrix rec- 
ognition suggests that a major role of the FNR is to transmit 
information about the state of the extracellular matrix to the 
cell. Rather than alterations  in FNR function somehow dic- 
tating cell behavior (e.g., by phosphorylation of the FNR in- 
ducing decreased FN binding and hence increased cell motil- 
ity  [Duband  et al.,  1988])  the FNR may  serve as a signal 
transducer between the external FN matrix and the cell regu- 
lating  adhesive  interactions  and  motility  (Duband  et  al., 
1986), cytodifferentiation  (Menko and Boettiger,  1987; Patel 
and  Lodish,  1988),  growth  promotion  (Bitterman  et  al., 
1983)  and  the  regulation of gene expression (Holderbaum 
and Ehrhart,  1986).  Accordingly,  it is important  to under- 
stand  the  mechanisms  of FN deposition  by  mesenchymal 
cells and signal transduction  by the FNR. Finally,  it scarcely 
must be emphasized that the extracellular matrix is a rich 
composite with marked regional heterogeneity.  Although we 
have focused on FN and the FNR, multiple cellular receptors 
are  utilized for adhesion even to matrices  formed in vitro 
(Wayner and Carter,  1987), and doubtless greater complex- 
ity exists in vivo. 
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